Impact of expected changes in national Papanicolaou test volume on the cytotechnology labor market: An impending crisis

American Journal of Clinical Pathology

Volumn 128, Issue 4, 2007, Pages 665-670

  Eltoum, Isam A ^a,b   Roberson, Janie ^a  

^a University of Alabama at Birmingham   (United States)

^b Kracke Bldg 609 ^*  (United States)

Author keywords

Demand and supply; Labor force; Technology; Total Papanicolaou test volume

Indexed keywords

WART VIRUS VACCINE;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOTECHNOLOGIST; FEMALE; HUMAN; MARKETING; MEDICAID; MEDICARE; PAPANICOLAOU TEST; PRIORITY JOURNAL; SCREENING TEST; SQUAMOUS CELL; VERRUCA VULGARIS; WART VIRUS;

ADOLESCENT; ADULT; CYTODIAGNOSIS; DELIVERY OF HEALTH CARE; FEMALE; HUMANS; MASS SCREENING; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATHOLOGY, CLINICAL; VAGINAL SMEARS;

EID: 35348865543     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/40DW4TG5TKNUEM71     Document Type: Article

References (20)

1. Bedrossian UK, Zaleski S. Cytotechnologist productivity standards: monitoring performance in a TQM environment. Diagn Cytopathol. 1997;17:403-405.
2. Eltoum IA, Roberson J. Impact of HPV testing, HPV vaccine development, and changing screening frequency on national Pap test volume: projections from the National Health Interview Survey (NHIS). Cancer. 2007;111:34-40.
3. Institute of Medicine. Allied Health Services: Avoiding Crises. Washington, DC: National Academy Press; 1989.
4. Vujicic M, Zurn P. The dynamics of the health labour market. Int J Health Plann Manage. 2006;21:101-115.
5. Wiseman C. National cytology proficiency testing update. Clinical Laboratory Improvement Advisory Committee Meeting (CLIAC), Atlanta, GA, February 2006.
6. Steward CA, Thompson NN. ASCP 2005 wage and vacancy survey of medical laboratories. LABMEDICINE. 2006;37:465-469.
7. American Society for Cytotechnology. ASCT 2005 cytotechnology wage and vacancy survey results. The Voice. March 2006;3:7-8. Available at http://www.asct.com/memonly/images/March_2006.pdf. Accessed August 9, 2007.
8. American Society for Cytotechnology. ASCT 2006 cytotechnology wage & vacancy survey. The Voice. January 2007;4:1. Available at http://www.asct.com/ newsletter/jan07/art1.html. Accessed August 9, 2007.
9. Jones BA, Davey DD. Quality management in gynecologic cytology using interlaboratory comparison. Arch Pathol Lab Med. 2000;124:672-681.
10. US Department of Health and Human Services, National Center for Health Statistics. National Health Interview Survey, 2000. Adult Sample. Hyattsville, MD: US Dept of Health and Human Services, National Center for Health Statistics; 2000.
11. Auerbach AJ, Kotlikoff LJ. Macroeconomics: An Integrated Approach. 2nd ed. Cambridge, MA: MIT Press; 1998.
12. ASCP Board of Registry. July-December 2005 Examination Statistics. BOR Newsletter. Spring 2006.
13. McMahon T. Inflation rate in percent for Jan 2000-present. Available at http://inflationdata.com/Inflation/Inflation_Rate/CurrentInflation.asp. Accessed August 9, 2007.
14. Swan J, Breen N, Coates RJ, et al. Progress in cancer screening practices in the United States: results from the 2000 National Health Interview Survey. Cancer. 2003;97:1528-1540.
15. US Census Bureau. Annual projections by single year of age by sex. Washington, DC: US Dept of Commerce, US Census Bureau; 2005.
16. US Food and Drug Administration. New device approval: Digene Hybrid Capture 2 High-Risk HPV DNA test-P890064 S009 A004. Rockville, MD: US Food and Drug Administration; 2003.
17. American College of Obstetricians and Gynecologists. ACOG practice bulletin: cervical cytology screening: number 45, August 2003. Int J Gynaecol Obstet. 2003;83:237-247.
18. Twombly R. US girls to receive HPV vaccine but picture unclear on potential worldwide use, acceptance. J Natl Cancer Inst. 2006;98:1030-1032.
19. Institute of Management and Administration. Diagnostic testing and technology report: anatomic pathology and cytology: continued growth driven by Pap testing. Washington G2 Reports. January 2007.
20. Irwin K, Montano D, Kasprzyk D, et al. Cervical cancer screening, abnormal cytology management, and counseling practices in the United States. Obstet Gynecol. 2006;108:397-409.